Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Australian Household Spending Dips in December as RBA Tightens Policy 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Korea Ginseng Corporation inaugurated its research and development (R&D) center in California. The leading South Korean ginseng producer said on Wednesday, March 15, that it has set up a facility in the United States to expand its presence in the American market while also boosting its sales overseas.
Korea Ginseng Corp. is the maker of the no. 1 ginseng brand in the world known as CheongKwanJang. The opening of its R&D center in the U.S. is a major step toward increasing its market share in the region. Moreover, the center was built so the company can continue developing Korean ginseng into a product that will suit the preference of Americans.
As per The Korea Herald, the ginseng products manufacturer said that with its new R&D center, it would conduct research to find ways of enhancing and broadening the use of its flagship red ginseng products currently being sold in the U.S.
The company especially wants to bolster its products' capability of improving customers' immunity and memory and reducing fatigue. Aside from product development, the center will also serve as a hub that will manage the manufacturing process and quality control of the health products that will be made there.
Korea Ginseng Corp. mentioned its R&D in California will further function as an office for its business ventures in neighboring foreign markets, including Central and South America. The facility will collect data about health drinks and food markets so the company can improve its products based on the information.
"Our US R&D Center will contribute to the construction of local production infrastructure while strengthening the development of customized ginseng products for local consumers," KGC's chief executive officer, Heo Chul Ho, said during the R&D center's inauguration. "The U.S. R&D center will contribute to building infrastructure for a localized manufacturing line as well as strengthening development for localized products."
In a separate press release, the CEO of KGC US, Heung Sil Lee, further said, "This will be a momentous year for our global business. As we meet the unique needs of our U.S. customers by actively developing products specifically tailored to their lifestyles."
